-
1Academic Journal
المؤلفون: Jhaveri, Komal L., Eli, Lisa Diamond, Wildiers, Hans P.M.W., Hurvitz, Sara Alsterlind, Guerrero-Zotano, Ángel L., Unni, Nisha, Brufsky, Adam M., Park, Haeseong, Waisman, James Ross, Yang, E. S., Spanggaard, Iben, Reid, Sonya A., Burkard, Mark E., Vinayak, Shaveta, Prat, Aleix, Arnedos, Mónica, Bidard, François Clément, Loi, Sherene M., Crown, John P.A., Bhave, Manali Ajay, Piha-Paul, S. A., Suga, Jennifer Marie, Chia, Stephen K.L., Saura, Cristina Bandín, Garcia-Saenz, José Ángel, Gambardella, Valentina, de Miguel, María José, Gal-Yam, Einav Nili, Rapael, A., Stemmer, Salomon Marcello, Ma, Cynthia X., Hanker, Ariella B., Ye, Dan, Goldman, Jonathan Wade, Bose, Ron, Peterson, Lindsay L., Bell, Joshua S.K., Frazier, A., Diprimeo, Daniel, Wong, Andrea Li Ann, Arteaga, Carlos L., Solit, David B.
المساهمون: Institut Curie - Saint Cloud (ICSC), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), National Cancer Institute, NCI, (P30-CA008748), Breast Cancer Research Foundation, BCRF, (R01-CA234361, R01CA224899), Memorial Sloan-Kettering Cancer Center, MSKCC, Puma Biotechnology, The SUMMIT study and the provision of editorial support byMiller Medical Communications Ltd. were supported byPuma Biotechnology, Inc. Funding support was provided tothe Memorial Sloan Kettering Cancer Center under the NCICancer Center support grant number P30-CA008748 . SL issupported by the National Breast Cancer Foundation ofAustralia Endowed Chair and the Breast Cancer ResearchFoundation, New York, NY, USA. DBS and correlative sciencestudies were supported by grant number R01-CA234361.MEB: Carbone Cancer Center, University of Wisconsin-Madison grant number P30CA014520 UW . CLA and ABH:grant number NCI R01CA224899.
المصدر: ISSN: 0923-7534.
مصطلحات موضوعية: ERBB2, HER2-mutant, hormone receptor-positive, metastatic breast cancer, neratinib, [SDV.CAN]Life Sciences [q-bio]/Cancer
Relation: info:eu-repo/semantics/altIdentifier/pmid/37597578; hal-04229497; https://hal.science/hal-04229497; https://hal.science/hal-04229497/document; https://hal.science/hal-04229497/file/1-s2.0-S0923753423008001-main.pdf; PUBMED: 37597578
-
2Academic Journal
المؤلفون: Jhaveri, Komal L., Eli, Lisa Diamond, Wildiers, Hans P.M.W., Hurvitz, Sara Alsterlind, Guerrero-Zotano, Ángel L., Unni, Nisha, Brufsky, Adam M., Park, Haeseong, Waisman, James Ross, Yang, E. S., Spanggaard, Iben, Reid, Sonya A., Burkard, Mark E., Vinayak, Shaveta, Prat, Aleix, Arnedos, Mónica, Bidard, François Clément, Loi, Sherene M., Crown, John P.A., Bhave, Manali Ajay, Piha-Paul, S. A., Suga, Jennifer Marie, Chia, Stephen K.L., Saura, Cristina Bandín, Garcia-Saenz, José Ángel, Gambardella, Valentina, de Miguel, María José, Gal-Yam, Einav Nili, Rapael, A., Stemmer, Salomon Marcello, Ma, Cynthia X., Hanker, Ariella B., Ye, Dan, Goldman, Jonathan Wade, Bose, Ron, Peterson, Lindsay L., Bell, Joshua S.K., Frazier, A., Diprimeo, Daniel, Wong, Andrea Li Ann, Arteaga, Carlos L., Solit, David B.
المساهمون: Institut Curie - Saint Cloud (ICSC), UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, National Cancer Institute, NCI, (P30-CA008748), Breast Cancer Research Foundation, BCRF, (R01-CA234361, R01CA224899), Memorial Sloan-Kettering Cancer Center, MSKCC, Puma Biotechnology, The SUMMIT study and the provision of editorial support byMiller Medical Communications Ltd. were supported byPuma Biotechnology, Inc. Funding support was provided tothe Memorial Sloan Kettering Cancer Center under the NCICancer Center support grant number P30-CA008748 . SL issupported by the National Breast Cancer Foundation ofAustralia Endowed Chair and the Breast Cancer ResearchFoundation, New York, NY, USA. DBS and correlative sciencestudies were supported by grant number R01-CA234361.MEB: Carbone Cancer Center, University of Wisconsin-Madison grant number P30CA014520 UW . CLA and ABH:grant number NCI R01CA224899.
المصدر: ISSN: 0923-7534.
مصطلحات موضوعية: ERBB2, HER2-mutant, hormone receptor-positive, metastatic breast cancer, neratinib, [SDV.CAN]Life Sciences [q-bio]/Cancer
Relation: info:eu-repo/semantics/altIdentifier/pmid/37597578; PUBMED: 37597578
-
3Academic Journal
المؤلفون: Jhaveri, Komal L., Eli, Lisa Diamond, Wildiers, Hans P.M.W., Hurvitz, Sara Alsterlind, Guerrero-Zotano, Ángel L., Unni, Nisha, Brufsky, Adam M., Park, Haeseong, Waisman, James Ross, Yang, E. S., Spanggaard, Iben, Reid, Sonya A., Burkard, Mark E., Vinayak, Shaveta, Prat, Aleix, Arnedos, Mónica, Bidard, François Clément, Loi, Sherene M., Crown, John P.A., Bhave, Manali Ajay, Piha-Paul, S. A., Suga, Jennifer Marie, Chia, Stephen K.L., Saura, Cristina Bandín, Garcia-Saenz, José Ángel, Gambardella, Valentina, de Miguel, María José, Gal-Yam, Einav Nili, Rapael, A., Stemmer, Salomon Marcello, Ma, Cynthia X., Hanker, Ariella B., Ye, Dan, Goldman, Jonathan Wade, Bose, Ron, Peterson, Lindsay L., Bell, Joshua S.K., Frazier, A., Diprimeo, Daniel, Wong, Andrea Li Ann, Arteaga, Carlos L., Solit, David B.
المساهمون: Institut Curie - Saint Cloud (ICSC), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), National Cancer Institute, NCI, (P30-CA008748), Breast Cancer Research Foundation, BCRF, (R01-CA234361, R01CA224899), Memorial Sloan-Kettering Cancer Center, MSKCC, Puma Biotechnology, The SUMMIT study and the provision of editorial support byMiller Medical Communications Ltd. were supported byPuma Biotechnology, Inc. Funding support was provided tothe Memorial Sloan Kettering Cancer Center under the NCICancer Center support grant number P30-CA008748 . SL issupported by the National Breast Cancer Foundation ofAustralia Endowed Chair and the Breast Cancer ResearchFoundation, New York, NY, USA. DBS and correlative sciencestudies were supported by grant number R01-CA234361.MEB: Carbone Cancer Center, University of Wisconsin-Madison grant number P30CA014520 UW . CLA and ABH:grant number NCI R01CA224899.
المصدر: ISSN: 0923-7534.
مصطلحات موضوعية: ERBB2, HER2-mutant, hormone receptor-positive, metastatic breast cancer, neratinib, [SDV.CAN]Life Sciences [q-bio]/Cancer
Relation: info:eu-repo/semantics/altIdentifier/pmid/37597578; hal-04229497; https://hal.science/hal-04229497; https://hal.science/hal-04229497/document; https://hal.science/hal-04229497/file/1-s2.0-S0923753423008001-main.pdf; PUBMED: 37597578